Search

Louie Garcia

from Menifee, CA
Age ~39
Get Report
Also known as:
Loui E Garcia, Lovie Garcia, Louie Garica
Related to:
Leilani M Garcia, 48Juan L Garcia, 45Monica D Mora, 49Brian SalazarMichelle Requejo, 53Brian R Salazar, 56Rosa Salazar, 59
Connected to:
A Garcia, 52A Garcia, 47Abbi Garcia, 42Abraham Garcia, 34Abrahan E Garcia, 37Acacia L Garcia, 30Acxel Garcia, 40Ada Garcia, 57Adalkiris E Garcia, 50Adamir Garcia, 33

Louie Garcia Phones & Addresses

  • Menifee, CA
  • Spring Valley, CA
  • Murrieta, CA
  • El Cajon, CA
  • Porterville, CA
  • Visalia, CA
  • Colton, CA
  • Santee, CA
  • Tulare, CA

Public records

Vehicle Records

Louie Garcia

View page
Address:
29869 Pacific Channel Way, Sun City, CA 92586
VIN:
1D7HA18277J517169
Make:
DODGE
Model:
RAM PICKUP 1500
Year:
2007

Resumes

Resumes

Louie Garcia Photo 1

Louie Garcia

View page
Location:
United States
Louie Garcia Photo 2

Louie Garcia

View page
Location:
United States
Louie Garcia Photo 3

Staff Research Associate At Pacira Pharmaceuticals, Inc.

View page
Position:
Staff Research Associate at Pacira Pharmaceuticals, Inc.
Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Work:
Pacira Pharmaceuticals, Inc.
Staff Research Associate
Education:
University of California, San Diego
BS, Biochemistry
Louie Garcia Photo 4

Louie Garcia

View page
Location:
United States
Louie Garcia Photo 5

Louie Garcia Murrieta, CA

View page
Work:
Milco Constructors INC.
Hinkley, CA
Jul 2013 to Apr 2014
Site-Expeditor
EnergyWorks LLC.
Annapolis, MD
Jul 2008 to Mar 2013
Project Manager/ Business Development Manager/QA/field engineer QC
Vestas Wind Systems
Portland, OR
Jul 2006 to Jul 2008
Resource Technician
United States Navy
San Diego, CA
Jul 2002 to Jul 2006
Avionics Technician
Education:
Ashford University
2011 to 2000
Information Technology Systems
Vincennes University
2005 to 2009
Business Administration

Publications

Us Patents

Sustained Release Formulation Of A Non-Steroidal Anti-Inflammatory Drug

View page
US Patent:
20120114740, May 10, 2012
Filed:
Oct 27, 2011
Appl. No.:
13/283450
Inventors:
Louie Daniel Garcia - San Diego CA, US
Liangjin Zhu - San Diego CA, US
William Joseph Lambert - San Diego CA, US
Gary Patou - Los Altos Hills GA, US
Assignee:
PACIRA PHARMACEUTICALS, INC - SAN DIEGO CA
International Classification:
A61K 9/127
A61K 31/192
A61K 31/407
A61P 29/00
A61K 31/40
A61K 31/421
A61K 31/5415
A61K 31/542
A61K 31/405
A61K 31/196
US Classification:
424450, 514420, 514569, 514411, 514567, 514423, 514413, 514570, 514374, 5142265, 5142245
Abstract:
Disclosed are formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs which minimize the side effects of unencapsulated non-steroidal anti-inflammatory drugs while maintaining or improving efficacy. Methods of making and administering the formulations comprising multivesicular liposomes and one or more non-steroidal anti-inflammatory drugs and their use as medicaments are also provided.

Sustained Release Formulation Of Methotrexate As A Disease-Modifying Antirheumatic Drug (Dmard) And An Anti-Cancer Agent

View page
US Patent:
20110280932, Nov 17, 2011
Filed:
Oct 28, 2010
Appl. No.:
12/914944
Inventors:
Louie Daniel Garcia - San Diego CA, US
Lois Gibson - Bradley Beach CA, US
William Lambert - San Diego CA, US
Benjamin W. Li - San Diego CA, US
Liangjin Zhu - San Diego CA, US
Assignee:
PACIRA PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 9/127
A61K 31/575
A61P 17/06
A61P 19/02
A61P 1/04
A61K 31/519
A61P 35/00
US Classification:
424450, 514249, 514171
Abstract:
Disclosed is are formulations comprising a multivesicular liposome and MTX, the administration of which results in a Cof MTX between 5% and 50% of the Cof an immediate release dosage form of MTX, the duration of which lasts from about 1 to about 30 days. Also disclosed are methods of treating autoimmune diseases and cancer by administering these formulations of MTX.

Multivesicular Liposome Formulations Of Dexmedetomidine

View page
US Patent:
20220273568, Sep 1, 2022
Filed:
Jul 9, 2020
Appl. No.:
17/625705
Inventors:
- San Diego CA, US
Patrick GHL. Boen - San Diego CA, US
Louie D. Garcia - San Diego CA, US
Paige N. Davis - San Diego CA, US
Hassan G. Hussein - San Diego CA, US
Kathleen D. A. Los - San Diego CA, US
International Classification:
A61K 9/127
A61K 31/4174
A61K 9/00
A61P 25/22
A61P 29/00
A61K 33/42
Abstract:
Some embodiments of the present application are related to multivesicular liposome formulations comprising dexmedetomidine (DXM) for the purpose of minimizing the side effects of immediate release formulation of dexmedetomidine while lengthening the duration of the effect with clinically meaniningful efficacy. Processes of making and administering DXM encapsulated multivesicular liposome formulations (DXM-MVLs) and their uses as medicaments are also provided.

Compositions Of Bupivacaine Multivesicular Liposomes

View page
US Patent:
20220233442, Jul 28, 2022
Filed:
Feb 1, 2022
Appl. No.:
17/590636
Inventors:
- San Diego CA, US
David J. Turnbull - San Diego CA, US
Soroush M. Ardekani - San Diego CA, US
Paige N. Davis - San Diego CA, US
Louie D. Garcia - San Diego CA, US
Stephanie M. Kurz - San Diego CA, US
Kathleen D. A. Los - San Diego CA, US
International Classification:
A61K 9/127
A61K 47/28
A61K 47/12
A61K 47/14
A61K 31/445
A61K 47/18
Abstract:
Embodiments of the present application relate to compositions of multivesicular liposomes (MVLs) and commercial manufacturing processes for making bupivacaine MVLs.

Manufacturing Of Bupivacaine Multivesicular Liposomes

View page
US Patent:
20220233446, Jul 28, 2022
Filed:
Jan 22, 2021
Appl. No.:
17/156422
Inventors:
- San Diego CA, US
David J. Turnbull - San Diego CA, US
Soroush M. Ardekani - San Diego CA, US
Paige N. Davis - San Diego CA, US
Louie D. Garcia - San Diego CA, US
Stephanie M. Kurz - San Diego CA, US
Kathleen D.A. Los - San Diego CA, US
International Classification:
A61K 9/127
A61K 31/451
A61K 47/18
B01F 3/08
B01F 3/22
B01D 61/14
B01D 63/02
B01D 69/02
Abstract:
Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations And Processes For Making The Same

View page
US Patent:
20180161275, Jun 14, 2018
Filed:
Nov 17, 2017
Appl. No.:
15/816916
Inventors:
- San Diego CA, US
Louie Daniel Garcia - San Diego CA, US
Stephanie Kurz - San Diego CA, US
Katherine Stone - San Diego CA, US
Ernest G. Schutt - San Diego CA, US
Vladimir Kharitonov - San Diego CA, US
International Classification:
A61K 9/127
A61K 31/555
A61K 47/24
A61K 9/00
A61P 29/00
Abstract:
Embodiments of the present disclosure are related to multivesicular liposome formulations encapsulating zinc meloxicam complex microparticles. Methods of making the zinc meloxicam complex microparticles and administering the zinc meloxicam complex microparticles encapsulated in multivesicular liposome formulations and their use as medicaments are also provided.

Multivesicular Liposome Formulations Of Tranexamic Acid

View page
US Patent:
20160206580, Jul 21, 2016
Filed:
Jan 20, 2016
Appl. No.:
15/002243
Inventors:
- San Diego CA, US
Louie Daniel Garcia - San Diego CA, US
Stephanie Kurz - San Diego CA, US
Vladimir Kharitonov - San Diego CA, US
International Classification:
A61K 31/195
A61K 9/00
A61K 9/127
Abstract:
Some embodiments of the present application are related to multivesicular liposome formulations comprising tranexamic acid (TXA) for the purpose of minimizing the side effects of unencapsulated tranexamic while maintaining or improving efficacy and lengthening the duration of the effect. Methods of making and administering the tranexamic acid encapsulated multivesicular liposome formulations and their use as medicaments are also provided.
Control profile
Louie Garcia from Menifee, CA, age ~39 Get Report